INVESTORS & MEDIA

Investor Relations

Investor Relations

We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product candidates in a range of diseases, including blindness-causing eye diseases, severe inflammatory conditions like asthma and atopic dermatitis, hematologic conditions, pain and infectious diseases such as Ebola and COVID-19.

Analyst Center

Interactive

Analyst Center

Interactive and downloadable financial data for investors and analysts

btn Analyst Center

Contact us

Investor Relations

914.847.7741

Media Relations

Email Alerts

IR Tools